UPDATE - Auriga Upgraded Herbalife (HLF) to Buy; Accumulate Shares on Dip
Tweet
Share
E-mailGet Alerts HLF Hot Sheet
Price: $8.88 -3.48%
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
8 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
UPDATE - Auriga upgraded Herbalife (NYSE: HLF) from Hold to Buy. PT raised from $66 to $68.
Analyst, Gary Albanese, said, "We are raising our recommendation on Herbalife and our Price Target following the company's Q1 results. The company's shares declined 20% yesterday likely based on speculation surrounding conference call questions by hedge fund manager David Einhorn. We did not hear any new material issues raised but his questions were concerns that have previously been raised. As a multi-level marketer, Herbalife's operating structure is different than traditional retailers. Despite these concerns, the company continues to demonstrate significant growth, which it demonstrated in Q1 which exceeded expectations. As we mentioned in our previous reports, our earlier concerns was based on relative value concerns as it was increasing priced at a premium compared to other multi-level markets. We believe the participation of Mr. Einhorn, not his specific questions, and his reputation as a short-seller led to the sell-off."
To see more ratings on HLF, Click Here
Analyst, Gary Albanese, said, "We are raising our recommendation on Herbalife and our Price Target following the company's Q1 results. The company's shares declined 20% yesterday likely based on speculation surrounding conference call questions by hedge fund manager David Einhorn. We did not hear any new material issues raised but his questions were concerns that have previously been raised. As a multi-level marketer, Herbalife's operating structure is different than traditional retailers. Despite these concerns, the company continues to demonstrate significant growth, which it demonstrated in Q1 which exceeded expectations. As we mentioned in our previous reports, our earlier concerns was based on relative value concerns as it was increasing priced at a premium compared to other multi-level markets. We believe the participation of Mr. Einhorn, not his specific questions, and his reputation as a short-seller led to the sell-off."
To see more ratings on HLF, Click Here
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MarineMax (HZO) PT Lowered to $35 at Stifel
- Keurig Dr Pepper (KDP) PT Raised to $39 at Jefferies
- Bristol-Myers Squibb Co. (BMY) PT Lowered to $64 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
Greenlight Capital, David Einhorn, Hedge Funds, AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
